Jovanović B, Temko D, Stevens LE, Seehawer M, Fassl A, Murphy K, Anand J, Garza K, Gulvady A, Qiu X, Harper NW, Daniels VW, Xiao-Yun H, Ge JY, Alečković M, Pyrdol J, Hinohara K, Egri SB, Papanastasiou M, Vadhi R, Font-Tello A, Witwicki R, Peluffo G, Trinh A, Shu S, Diciaccio B, Ekram MB, Subedee A, Herbert ZT, Wucherpfennig KW, Letai AG, Jaffe JD, Sicinski P, Brown M, Dillon D, Long HW, Michor F, Polyak K.
Heterogeneity and transcriptional drivers of triple-negative breast cancer [Internet]. Cell Rep 2023;42(12):113564.
Publisher's Version Schmaier AA, Anderson PF, Chen SM, El-Darzi E, Aivasovsky I, Kaushik MP, Sack KD, Hartzell HC, Parikh SM, Flaumenhaft R, Schulman S.
TMEM16E regulates endothelial cell procoagulant activity and thrombosis [Internet]. J Clin Invest 2023;133(11):e163808.
Publisher's Version Chen D-Y, Chin CV, Kenney D, Tavares AH, Khan N, Conway HL, Liu GQ, Choudhary MC, Gertje HP, O'Connell AK, Adams S, Kotton DN, Herrmann A, Ensser A, Connor JH, Bosmann M, Li JZ, Gack MU, Baker SC, Kirchdoerfer RN, Kataria Y, Crossland NA, Douam F, Saeed M.
Spike and nsp6 are key determinants of SARS-CoV-2 Omicron BA.1 attenuation [Internet]. Nature 2023;615:143-150.
Publisher's Version Durall RT, Huang J, Wojenski L, Huang Y, Gokhale PC, Leeper BA, Nash JO, Ballester PL, Davidson S, Shlien A, Sotirakis E, Bertaux F, Dubus V, Luo J, Wu CJ, Keskin DB, Eagen KP, Shapiro GI, French CA.
The BRD4-NUT fusion alone drives malignant transformation of NUT carcinoma [Internet]. Cancer Res 2023;(Oct 11)
Publisher's Version Park DS, Nguyen SC, Isenhart R, Shah PP, Kim W, Barnett RJ, Chandra A, Luppino JM, Harke J, Wai M, Walsh PJ, Abdill RJ, Yang R, Lan Y, Yoon S, Yunker R, Kanemaki MT, Vahedi G, Phillips-Cremins JE, Jain R, Joyce EF.
High-throughput Oligopaint screen identifies druggable 3D genome regulators. Nature 2023;620:209–217.